Literature DB >> 22796390

The effectiveness of physiotherapy functional restoration for post-acute low back pain: a systematic review.

Matthew C Richards1, Jon J Ford, Sarah L Slater, Andrew J Hahne, Luke D Surkitt, Megan Davidson, Joan M McMeeken.   

Abstract

BACKGROUND: The effectiveness of multidisciplinary treatment for post-acute (>6 weeks) low back pain (LBP) has been established. Physiotherapists have sufficient training to conduct less intensive functional restoration. The effectiveness of physiotherapy functional restoration (PFR) has not been evaluated using current systematic review methodology.
OBJECTIVES: To determine the effects of PFR for post-acute LBP. DATA SOURCES: Electronic databases searched include: MEDLINE, EMBASE, CINAHL, PsycINFO, PEDro and Cochrane CENTRAL. TRIAL ELIGIBILITY CRITERIA: Randomised controlled trials of physiotherapy treatment for post-acute LBP combining exercise and cognitive-behavioural intervention compared with other intervention, no intervention or placebo. TRIAL APPRAISAL AND SYNTHESIS
METHODS: Two authors independently extracted data. Risk of bias was assessed using the PEDro scale and overall quality of the body of evidence was assessed using GRADE (Grading of Recommendations, Assessment, Development and Evaluation). Treatment effect sizes and 95% confidence intervals were calculated for pain, function and sick leave.
RESULTS: Sixteen trials were included. Heterogeneity prevented meta-analysis for most comparisons. Meta-analyses showed moderate to high quality evidence of significant but small effects favouring PFR compared with advice for intermediate term function and intermediate and long term pain. There was however low to moderate quality evidence that PFR was no more effective than a range of other treatment types. Heterogeneous trials frequently contributed to very low quality evidence.
CONCLUSIONS: Moderate to high quality evidence was found of small effects favouring PFR compared with advice. Preliminary evidence suggested PFR is not different to other treatment types. Further high quality research is required replicating existing trial protocols.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22796390     DOI: 10.1016/j.math.2012.06.005

Source DB:  PubMed          Journal:  Man Ther        ISSN: 1356-689X


  6 in total

1.  Introducing Acceptance and Commitment Therapy to a physiotherapy-led pain rehabilitation programme: an Action Research study.

Authors:  Karen L Barker; Leila Heelas; Francine Toye
Journal:  Br J Pain       Date:  2015-05-18

Review 2.  Non-Specific Low Back Pain.

Authors:  Jean-François Chenot; Bernhard Greitemann; Bernd Kladny; Frank Petzke; Michael Pfingsten; Susanne Gabriele Schorr
Journal:  Dtsch Arztebl Int       Date:  2017-12-25       Impact factor: 5.594

3.  Severity of back pain may influence choice and order of practitioner consultations across conventional, allied and complementary health care: a cross-sectional study of 1851 mid-age Australian women.

Authors:  David Sibbritt; Romy Lauche; Tobias Sundberg; Wenbo Peng; Craig Moore; Alex Broom; Emma Kirby; Jon Adams
Journal:  BMC Musculoskelet Disord       Date:  2016-09-17       Impact factor: 2.362

Review 4.  The Evolving Case Supporting Individualised Physiotherapy for Low Back Pain.

Authors:  Jon Ford; Andrew Hahne; Luke Surkitt; Alexander Chan; Matthew Richards
Journal:  J Clin Med       Date:  2019-08-28       Impact factor: 4.241

5.  Live Video Mind-Body Program for Patients With Knee Osteoarthritis, Comorbid Depression, and Obesity: Development and Feasibility Pilot Study.

Authors:  Ryan A Mace; Jonathan Greenberg; Nicole Lemaster; Brooke Duarte; Terence Penn; Millan Kanaya; James D Doorley; Jessica L Burris; Cale A Jacobs; Ana-Maria Vranceanu
Journal:  JMIR Form Res       Date:  2022-04-27

Review 6.  Effectiveness of workplace intervention strategies in lower back pain prevention: a review.

Authors:  Danuta Roman-Liu; Joanna KamiŃska; Tomasz Tokarski
Journal:  Ind Health       Date:  2020-09-24       Impact factor: 2.179

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.